AGA Medical Corporation
Plymouth, MN 55442
Share:
AGA Medical Corporation Receives European CE Mark Approval for the AMPLATZER-® Duct Occluder II
MINNEAPOLIS, Feb. 11 -- AGA Medical Corporation ( AGA ) announced today it received European CE Mark approval for the AMPLATZERÃ-® Duct Occluder II ( ADO II ). AGA also announced the immediate availability and launch of the device in Europe. The ADO II expands the AGA family of occlusion devices designed to occlude or close a patent ductus arteriosus ( PDA ), a type of congenital heart defect...
Read More »AGA Medical Corporation Receives European CE Mark Approval for the AMPLATZER-® Duct Occluder II
MINNEAPOLIS, Feb. 11 -- AGA Medical Corporation ( AGA ) announced today it received European CE Mark approval for the AMPLATZERÃ-® Duct Occluder II ( ADO II ). AGA also announced the immediate availability and launch of the device in Europe. The ADO II expands the AGA family of occlusion devices designed to occlude or close a patent ductus arteriosus ( PDA ), a type of congenital heart defect...
Read More »